Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:8
  • preuzimanja u poslednjih 30 dana:7
članak: 3 od 8  
Back povratak na rezultate
Scripta Medica
2019, vol. 50, br. 1, str. 13-18
jezik rada: engleski
vrsta rada: izvorni naučni članak
objavljeno: 05/07/2019
doi: 10.5937/scriptamed50-21828
The prevalence of smoking and its impact on disability in multiple sclerosis
(naslov ne postoji na srpskom)
Klinički centar Republike Srpske, Klinika za neurologiju, Banja Luka, Republika Srpska, BiH + Univerzitet u Banjoj Luci, Medicinski fakultet, Republika Srpska, BiH



(ne postoji na srpskom)
Introduction: Etiology of multiple sclerosis (MS) involves multi-factorial interactions among genetic and environmental factors. Cigarette smoking is one of the most important environmental factors that increase the disease risk by about 50%. The aim of this research was to assess the prevalence of smoking in MS patients compared to the general population, and to assess the association between smoking and physical disability in MS patients. Materials and Methods: A cross-sectional study included 100 MS patients and 50 healthy people. For estimation of the degree of physical disability, the Expanded Disability Status Scale (EDSS) was used, and for clinical and demographic data a general questionnaire was used. In order to collect data on the smoking, the questionnaire for examining risk factors for vascular disease among patients with MS was used. Results: Analysis of smoking incidence showed that, between MS and control group, smoking was a dependent variable (X2 = 6.258, p = 0.04). There was no statistically significant difference in the number of cigarettes, nor in the duration of smoking. There was no significant correlation between smoking in MS group and the index of disease progression (r=0.216, p=0.133). Also, the relationship between EDSS and smoking had no statistical significance, as well as between the disease course and smoking (X2 = 1.531, p = 0.216). Conclusion: Although it seems reasonable to restrict or refrain from smoking in patients with MS there was no significant evidence of smoking and disease progression correlation.

Ključne reči


Antonovsky, A., Leibovitz, U., Smith, H.A. (1965) Epidemiologic study of multiple sclerosis in Israel. I. An overall reviev of methods and findings. Arch Neurol, 13: 183-93
Asadollahi, S., Fakhri, M., Heidari, K., Zandieh, A., Vafaee, R., Mansouri, B. (2013) Cigarette smoking and associated risk of multiple sclerosis in the Iranian population. Journal of Clinical Neuroscience, 20(12): 1747-1750
Auer, M., Bsteh, G., Hegen, H., di Pauli, F., Wurth, S., Berger, T., Deisenhammer, F. (2018) Smoking is not associated with higher prevalence of JC virus in MS patients. European Journal of Clinical Microbiology & Infectious Diseases, 37(5): 907-910
Carlens, C., Hergens, M.P., Grunewald, J., Ekbom, A., Eklund, A., Höglund, C.O., Askling, J. (2010) Smoking, Use of Moist Snuff, and Risk of Chronic Inflammatory Diseases. American Journal of Respiratory and Critical Care Medicine, 181(11): 1217-1222
Compston, A., Ebers, G., Lassmann, H., McDonald, I., Matthews, B., Wekerle, H. (1998) McAlpine's multiple sclerosis. London: Churchill Livingstone, 3rd ed
Compston, A., Coles, A. (2002) Multiple sclerosis. Lancet, 359(9313): 1221-1231
Dhooghe, M.B., Haentjens, P., Nagels, G., de Keyser, J. (2012) Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol, 19(4):616-24
di Pauli, F., Reindl, M., Ehling, R., et al. (2008) Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler, 14: 1026-1056
Ghadirian, P., Dadgostar, B., Azani, R., Maisonneuve, P. (2001) A case-control study of the association between socio-demographic, lifestyle and medicalhistory factors and multiple sclerosis. Can J Public Health, 92: 281-286
Hawkes, C.H. (2007) Smoking is a risk factor for multiple sclerosis: A metanalysis. Multiple Sclerosis Journal, 13(5): 610-615
Healy, B.C., Ali, E.N., Guttmann, C.R.G., Chitnis, T., Glanz, B.I., Buckle, G., Houtchens, M., Stazzone, L., Moodie, J., Berger, A.M., Duan, Y., Bakshi, R., Khoury, S., Weiner, H., Ascherio, A. (2009) Smoking and Disease Progression in Multiple Sclerosis. Archives of Neurology, 66(7): 858-864
Hedstrom, A.K., Baarnhielm, M., Olsson, T., Alfredsson, L. (2009) Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology, 73(9): 696-701
Hedström, A.K. (2019) Smoking and its interaction with genetics in MS etiology. Multiple Sclerosis Journal, 25(2): 180-186
Hedström, A.K. (2018) Smoking is an important risk factor for MS that overall increases the risk of the disease with approximately 50%. Mult Scler, 1352458518801727-1352458518801727
Hedström, A.K., Bäärnhielm, M., Olsson, T., Alfredsson, L. (2011) Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Multiple Sclerosis Journal, 17(7): 788-793
Hedström, A.K., Ryner, M., Fink, K., Fogdell-Hahn, A., Alfredsson, L., Olsson, T., Hillert, J. (2014) Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a. Multiple Sclerosis Journal, 20(4): 445-450
Hernan, M.A., Olek, M.J., Ascherio, A., et al. (2001) Cigarette Smoking and Incidence of Multiple Sclerosis. American Journal of Epidemiology, 154(1): 69-74
Hernán, M.A., Jick, S.S., Logroscino, G., Olek, M.J., Ascherio, A., Jick, H.S. (2005) Cigarette smoking and the progression of multiple sclerosis. Brain, 128(6): 1461-1465
Khurana, S.R., Bamer, A.M., Turner, A.P., Wadhwani, R.V., Bowen, J.D., Leipertz, S.L., Haselkorn, J.K. (2009) The Prevalence of Overweight and Obesity in Veterans with Multiple Sclerosis. American Journal of Physical Medicine & Rehabilitation, 88(2): 83-91
Kurtzke, J.F. (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11): 1444-1444
Lalmohamed, A., Bazelier, M.T., van Staa, T.P., Uitdehaag, B.M.J., Leufkens, H.G.M., de Boer, A., de Vries, F. (2012) Causes of death in patients with multiple sclerosis and matched referent subjects: A population-based cohort study. European Journal of Neurology, 19(7): 1007-1014
Manouchehrinia, A., Tench, C.R., Maxted, J., Bibani, R.H., Britton, J., Constantinescu, C.S. (2013) Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain, 136(7): 2298-2304
Marie, R.A., Horwitz, R.I., Cutter, G., et al. Smokers with multiple sclerosisare more likely to report co-
Mikaeloff, Y., Caridade, G., Tardieu, M., Suissa, S. (2007) Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain, 130(10): 2589-2595
Mohamed-Ali, V., Goodrick, S., Rawesh, A., et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab, 82: 4196-200
Montgomery, S.M., Bahmanyar, S., Hillert, J., Ekbom, A., Olsson, T. (2008) Maternal smoking during pregnancy and multiple sclerosis amongst offspring. European Journal of Neurology, 15(12): 1395-1399
Munger, K.L., Levin, L.I., Hollis, B.W., Howard, N.S., Ascherio, A. (2006) Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis. JAMA, 296(23): 2832-2832
Olsson, T., Barcellos, L.F., Alfredsson, L. (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nature Reviews Neurology, 13(1): 25-36
Pekmezovic, T., Drulovic, J., Milenkovic, M., Jarebinski, M., Stojsavljevic, N., Mesaros, S., Kisic, D., Kostic, J. (2006) Lifestyle Factors and Multiple Sclerosis: A Case-Control Study in Belgrade. Neuroepidemiology, 27(4): 212-216
Petersen, E.R., Søndergaard, H.B., Laursen, J.H., Olsson, A.G., Börnsen, L., Soelberg, S.P., Sellebjerg, F., Bang, O.A. (2018) Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis. Multiple Sclerosis Journal, 2: 135245851879175-135245851879175
Pittas, F., Ponsonby, A.L., Mei, I.A.F., Taylor, B.V., Blizzard, L., Groom, P., Ukoumunne, O.C., Dwyer, T. (2009) Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. Journal of Neurology, 256(4): 577-585
Salzer, J., Stenlund, H., Sundström, P. (2014) The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age. Multiple Sclerosis Journal, 20(6): 747-750
Salzer, J., Hallmans, G., Nyström, M., Stenlund, H., Wadell, G., Sundström, P. (2013) Smoking as a risk factor for multiple sclerosis. Multiple Sclerosis Journal, 19(8): 1022-1027
Sena, A., Couderc, R., Ferret-Sena, V., Pedrosa, R., Andrade, M.L., Araujo, C., Roque, R., Cascais, M.J., Morais, M.G. (2009) Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis. European Journal of Neurology, 16(7): 832-837
Sundström, P., Nyström, L., Hallmans, G. (2008) Smoke exposure increases the risk for multiple sclerosis. European Journal of Neurology, 15(6): 579-583
Sundström, P., Nyström, L. (2008) Smoking worsens the prognosis in multiple sclerosis. Multiple Sclerosis Journal, 14(8): 1031-1035
Tardieu, M., Mikaeloff, Y. (2008) Multiple sclerosis in children: Environmental risk factors. Bull Acad Natl Med, 192(3): 507-516
Thacker, E.L., Mirzaei, F., Ascherio, A. (2006) Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Annals of Neurology, 59(3): 499-503
Weiland, T.J., Hadgkiss, E.J., Jelinek, G.A., Pereira, N.G., Marck, C.H., van der Meer, D.M. (2014) The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. Journal of the Neurological Sciences, 336(1-2): 211-219
Zivadinov, R., Weinstock-Guttman, B., Hashmi, K., Abdelrahman, N., Stosic, M., Dwyer, M., Hussein, S., Durfee, J., Ramanathan, M. (2009) Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology, 73(7): 504-510